BLUE BELL, Pa.--(BUSINESS WIRE)--VGX Pharmaceuticals today announced that it has been granted U.S. Patent number 7,245,963 titled “Electrode Assembly for Constant-Current Electroporation and Use.” The patent covers a new device for the delivery of macromolecules, including DNA plasmids, to tissues.
